SPY317.59+3.21 1.02%
DIA260.82+3.58 1.39%
IXIC10,617.44+69.69 0.66%

Can-Fite Announces Final Data Analysis From Phase II Nash Study: Highly Significant And Sustained Reduction In Liver Fat Volume Throughout Study Period; Reports Highly Significant And Sustained Reduction In Liver Fat Volume Throughout Study Period

Benzinga · -